Pharmaceuticals, Biotechnology and Life Sciences
Epizyme’s Next EPIsode: Vision for Rewriting Oncology Treatment with Epigenetics Showcased New Five-Year Corporate Strategy
Preliminary Safety and Activity Data from Ongoing Clinical Trials for TAZVERIK® Combinations in Follicular Lymphoma and Pro…
Epizyme’s Next EPIsode: Vision for Rewriting Oncology Treatment with Epigenetics Showcased New Five-Year Corporate Strategy
Preliminary Safety and Activity Data from Ongoing Clinical Trials for TAZVERIK® Combinations in Follicular Lymphoma and Pro…
MINNEAPOLIS–(BUSINESS WIRE)–NAMSA®, the world’s only 100% medical device-focused Contract Research Organization (CRO) providing full continuum development solutions, announced today its acquisition of Minneapolis-based American Preclinical Services (…
HENDERSON, Nev.–(BUSINESS WIRE)–Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, today presented results from Cohort 3 and initial twice daily (BID) dosing safety and efficacy da…
HENDERSON, Nev.–(BUSINESS WIRE)–Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, today presented results from Cohort 3 and initial twice daily (BID) dosing safety and efficacy da…
DUBLIN–(BUSINESS WIRE)–The “Biohacking Market Share, Size, Trends, Industry Analysis Report, By Type; By Product; By Application; By End Use; By Regions; Segment Forecast, 2020-2027” report has been added to ResearchAndMarkets.com’s offering.
The gl…
DUBLIN–(BUSINESS WIRE)–The “Market Spotlight: Neuroendocrine tumors (NET)” report has been added to ResearchAndMarkets.com’s offering.
This Market Spotlight report covers the Neuroendocrine Tumors market, comprising key marketed and pipeline drugs, …
Small Business Innovation Research Program Provides Seed Funding for R&D
SAN FRANCISCO–(BUSINESS WIRE)–$AI #AI–VeriSIM Life has been awarded a National Science Foundation (NSF) Small Business Innovation Research (SBIR) grant for $255,908 to co…
DUBLIN–(BUSINESS WIRE)–The “Pharma 4.0” report has been added to ResearchAndMarkets.com’s offering.
This report provides detailed exposure to the Pharma 4.0 market. This report also highlights the current and future market potential of Pharma 4.0 al…
DUBLIN–(BUSINESS WIRE)–The “Pharma 4.0” report has been added to ResearchAndMarkets.com’s offering.
This report provides detailed exposure to the Pharma 4.0 market. This report also highlights the current and future market potential of Pharma 4.0 al…